Clinical and histologic determinants of mortality for patients with Barrett's esophagus-related T1 esophageal adenocarcinoma. - Wikidata - awgldk - TriplyDB

Clinical and histologic determinants of mortality for patients with Barrett's esophagus-related T1 esophageal adenocarcinoma.

Clinical and histologic determinants of mortality for patients with Barrett's esophagus-related T1 esophageal adenocarcinoma.

http://www.wikidata.org/entity/Q35107000

about

Barrett's esophagus in 2016: From pathophysiology to treatment Outcomes of submucosal (T1b) esophageal adenocarcinomas removed by endoscopic mucosal resection.Is endoscopic ultrasound examination necessary in the management of esophageal cancer?Pathology of esophageal cancer and Barrett's esophagus.

P2860

Q26751171-ACC87355-C536-43F8-9306-141AE4799473 Q37507972-02EDF2AA-6484-41EC-9540-5DF4DB64002E Q37629689-34F50021-FD57-46EF-A17F-C52D65DAB9A7 Q37747362-F8BC53E8-250D-425A-A7A0-F5BB2697CC7A

P2860

Clinical and histologic determinants of mortality for patients with Barrett's esophagus-related T1 esophageal adenocarcinoma.

http://www.wikidata.org/entity/Q35107000

description

2014 nî lūn-bûn

@nan

2014 թուականի Օգոստոսին հրատարակուած գիտական յօդուած

@hyw

2014 թվականի օգոստոսին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

name

Clinical and histologic determ ...... T1 esophageal adenocarcinoma.

@ast

Clinical and histologic determ ...... T1 esophageal adenocarcinoma.

@en

type

label

Clinical and histologic determ ...... T1 esophageal adenocarcinoma.

@ast

Clinical and histologic determ ...... T1 esophageal adenocarcinoma.

@en

prefLabel

Clinical and histologic determ ...... T1 esophageal adenocarcinoma.

@ast

Clinical and histologic determ ...... T1 esophageal adenocarcinoma.

@en

P1433

Q35107000-635EAD15-703F-4D51-89BF-CDA9881A7055

P1476

Q35107000-CFB4D54E-5C1B-4B23-872F-8D8A5BA6857A

P2093

Q35107000-29FB0758-B849-4131-949D-4649C9EED41D

Q35107000-2F98AC01-EE26-4AAC-BC9B-02B5919D2222

Q35107000-6A2D2D51-5154-4C3D-AC4E-ECEDCBF0B366

Q35107000-80EA1ABA-2AB3-4D69-B6C4-D8C69568C22B

Q35107000-8A896EC4-93E1-4FEF-B22D-09864ED5E2AA

Q35107000-9C187FA5-8734-480D-8A35-C3D2B4246568

Q35107000-BBF5BC5C-567A-4B35-8A33-1F41C5A3770E

Q35107000-D0807AFE-E2BE-4417-85AB-765360CC40B8

P2860

Q35107000-11E9D3A9-6554-4E25-A1B1-5758B9E6339D

Q35107000-1B98AF4B-2377-4289-834A-A278A81B7D2E

Q35107000-20040F00-39F3-4B64-998F-505716205AB1

Q35107000-39C0AD30-BB00-4B4E-97FE-37AA6795EA18

Q35107000-43555457-1E58-45B1-9D0C-84C9D811FEFC

Q35107000-513EA16E-5780-4E82-B86C-E5412BCB14BD

Q35107000-694EEF6F-133F-4AE4-8098-1BBF549959B5

Q35107000-80B04ECF-375C-44CF-B468-BE368D797525

Q35107000-A1644BEF-3B6C-49C3-AC9E-424F64944E5A

Q35107000-AA503C6B-9531-47BB-AD8D-CAB6D25AF64D

P304

Q35107000-D9694DAA-871B-4DFC-A6BD-39EC2CC925EB

P31

Q35107000-A3EAEB81-57E2-461A-829A-A74C6FFC03FE

P356

Q35107000-085224E6-519B-440D-9FDF-8FC73213B1A4

P407

Q35107000-E958453C-C12D-4BED-9999-F6D3E975B09E

P433

Q35107000-075302A5-476C-43F7-BBF0-3EF9CFD154D8

P478

Q35107000-A1199AE4-33B6-447E-A15F-BAF25904B72D

P50

Q35107000-B0F852EC-BAD3-428B-AD3E-C40CC0EC5941

P577

Q35107000-DAC813B7-86C9-43DD-AFA9-5E4052AA5BB6

P698

Q35107000-E70CAF54-4563-409D-B879-91890CBDF8E0

P932

Q35107000-59F10386-F068-442A-B3D0-844C917A426F

P356

J.CGH.2014.08.016

P1433

Clinical Gastroenterology and Hepatology

P1476

Clinical and histologic determ ...... T1 esophageal adenocarcinoma.

@en

P2093

Cadman L Leggett

http://www.w3.org/2001/XMLSchema#string

Cathy D Schleck

http://www.w3.org/2001/XMLSchema#string

Jason T Lewis

http://www.w3.org/2001/XMLSchema#string

Kelly T Dunagan

http://www.w3.org/2001/XMLSchema#string

Kenneth K Wang

http://www.w3.org/2001/XMLSchema#string

Lori S Lutzke

http://www.w3.org/2001/XMLSchema#string

Prasad G Iyer

http://www.w3.org/2001/XMLSchema#string

Tsung Teh Wu

http://www.w3.org/2001/XMLSchema#string

P2860

The risk of lymph-node metastases in patients with high-grade dysplasia or intramucosal carcinoma in Barrett's esophagus: a systematic review

A comparison of endoscopic treatment and surgery in early esophageal cancer: an analysis of surveillance epidemiology and end results data.

Esophagectomy for T1 esophageal cancer: outcomes in 100 patients and implications for endoscopic therapy

Esophageal carcinoma: depth of tumor invasion is predictive of regional lymph node status.

Endoscopic and surgical treatment of mucosal (T1a) esophageal adenocarcinoma in Barrett's esophagus.

Survival of patients with superficial esophageal adenocarcinoma after endoscopic treatment vs surgery.

The prevalence of lymph node metastases in patients with T1 esophageal adenocarcinoma a retrospective review of esophagectomy specimens.

Long-term efficacy and safety of endoscopic resection for patients with mucosal adenocarcinoma of the esophagus.

Predicting lymph node metastases in early esophageal adenocarcinoma using a simple scoring system.

Comparison between endoscopic and surgical resection of mucosal esophageal adenocarcinoma in Barrett's esophagus at two high-volume centers.

P304

658-64.e1-3

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.CGH.2014.08.016

http://www.w3.org/2001/XMLSchema#string

P407

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

13

http://www.w3.org/2001/XMLSchema#string

P50

Alan R. Zinsmeister

P577

2014-08-20T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

25151255

http://www.w3.org/2001/XMLSchema#string

P932

4336231

http://www.w3.org/2001/XMLSchema#string